Evidence map›Paper›PMID 19855399›Full record

ArticleNature medicine2009

Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Yu Liang, Jodi L Vogel, Aarthi Narayanan, Hua Peng, Thomas M Kristie

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 282 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yu LiangLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, MD, USA.
Jodi L Vogel
Aarthi Narayanan
Hua Peng
Thomas M Kristie
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

Transcriptional control of herpes simplex virus lytic infection and latency-reactivation cyclesZIAAI000712 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KRISTIE, THOMAS M · 2009 to 2025
$13.0M
Regulation Of Transcription Of Herpes Simplex VirusZ01AI000712 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KRISTIE, THOMAS M · 1994 to 2008
$847k
Intramural NIH HHS Z01 AI000712
6 · The paper itself

Abstract

Reversible methylation of histone tails serves as either a positive signal recognized by transcriptional assemblies or a negative signal that result in repression. Invading viral pathogens that depend upon the host cell's transcriptional apparatus are also subject to the regulatory impact of chromatin assembly and modifications. Here we show that infection by the alpha-herpesviruses, herpes simplex virus (HSV) and varicella zoster virus (VZV), results in the rapid accumulation of chromatin bearing repressive histone H3 Lys9 methylation. To enable expression of viral immediate early (IE) genes, both viruses use the cellular transcriptional coactivator host cell factor-1 (HCF-1) to recruit the lysine-specific demethylase-1 (LSD1) to the viral immediate early promoters. Depletion of LSD1 or inhibition of its activity with monoamine oxidase inhibitors (MAOIs) results in the accumulation of repressive chromatin and a block to viral gene expression. As HCF-1 is a component of the Set1 and MLL1 histone H3 Lys4 methyltransferase complexes, it thus coordinates modulation of repressive H3 Lys9 methylation levels with addition of activating H3 Lys4 trimethylation marks. Strikingly, MAOIs also block the reactivation of HSV from latency in sensory neurons, indicating that the HCF-1 complex is a crucial component of the reactivation mechanism. The results support pharmaceutical control of histone modifying enzymes as a strategy for controlling herpesvirus infections.

Indexed as

AnimalsCell Line, TransformedChromatin ImmunoprecipitationDNA ReplicationEnzyme ActivationGangliaGene Expression Regulation, ViralGreen Fluorescent ProteinsHerpesvirus 1, HumanHerpesvirus 3, HumanHistone DemethylasesHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHost Cell Factor C1HumansLysineGreen Fluorescent ProteinsHCFC1 protein, humanHistone DemethylasesHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHost Cell Factor C1KDM1A protein, humanLysineMonoamine Oxidase InhibitorsPargylinePhencyclidinePiperidinesRNA, Small InterferingtenocyclidineThiophenes

Identifiers

PMID19855399
PMCPMC2783573
OpenAlexW2125161768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.